Grupo Español Multidisciplinar de Melanoma

12 clinical trials · Sponsor

Record	Firm	Date
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma (NCT07057596)	Grupo Español Multidisciplinar de Melanoma	2025-07-18
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients (NCT06906822)	Grupo Español Multidisciplinar de Melanoma	2025-06-10
Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases (NCT06887088)	Grupo Español Multidisciplinar de Melanoma	2025-05-29
Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases. (NCT05542342)	Grupo Español Multidisciplinar de Melanoma	2022-09-23
Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma (NCT04184518)	Grupo Español Multidisciplinar de Melanoma	2020-05-01
Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain (NCT03898908)	Grupo Español Multidisciplinar de Melanoma	2019-07-18
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain (NCT03605771)	Grupo Español Multidisciplinar de Melanoma	2018-08-07

Every clearance here is in the API, with alerts when new ones post.